Improved survival after prophylactic portal nondecompression surgery for esophageal varices: A randomized clinical trial

Kiyoshi Inokuchi, Cooperative Study Group of Portal Hypertension of Japan – 1 July 1990 – To evaluate prophylactic surgery for esophageal varices, a prospective randomized controlled trial was begun in 1980 by the Japanese Research Society for Portal Hypertension. Methods of operation included selective shunts and nonshunting interruption procedures. One hundred and twelve Japanese patients, in whom endoscopic findings suggested risk of bleeding but who had no bleeding episode, were randomly allocated to the operated group of 60 patients or nonoperated group of 52 patients.

Hepatic expression of intercellular adhesion molecule‐1 (ICAM‐1) in viral hepatitis B

Riccardo Volpes, Joost J. van den Oord, Valeer J. Desmet – 1 July 1990 – The in situ distribution patterns of intercellular adhesion molecule‐1 and human leukocyte antigen‐DR antigens were studied in serial sections of 61 liver biopsy specimens from patients with hepatitis B virus infection using immunohistochemical techniques.

Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids

Karin Vanderkerken, Luc Bouwens, Eddie Wisse – 1 July 1990 – Pit cells, or large granular lymphocytes, with natural tumoricidal activity are found in the sinusoids of normal rat liver. Hepatic large granular lymphocytes are heterogeneous and can be subdivided into two subsets. These subsets were compared with peripheralblood large granular lymphocytes and were found to differ phenotypically and functionally.

Auxiliary liver transplantation: A negative viewpoint

Abraham A. Shaked, Ronald W. Busuttil – 1 July 1990 – Auxiliary heterotopic liver transplantation is theoretically attractive because it leaves the recipient's liver in place. The surgical trauma of hepatectomy is avoided, and failure of the graft does not necessarily lead to the death of the patient or a second, emergency transplantation. Another advantage is that matching the body sizes of the donor and the recipient is not mandatory, which increases the number of possible donors. However, previous clinical results of auxiliary liver transplantation have been poor.

Recombinant human γ‐interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

Patrick Marcellin, Marie‐Anne Loriot, Nathalie Boyer, Michéle Martinot‐Peignoux, Claude Degott, Françoise Degos, Maud Brandely, Bernard Lenfant, Jean‐Pierre Benhamou – 1 July 1990 – Pharmacokinetics, tolerance and biological effects of human recombinant γ‐interferon were studied in 12 patients with chronic active hepatitis B.

Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: Role of immunostaining, dna hybridization and culture of hepatic tissue

Carlos V. Paya, Keith E. Holley, Russell H. Wiesner, Kumaravelu Balasubramaniam, Thomas F. Smith, Mark J. Espy, Jurgen Ludwig, Kenneth P. Batts, Paul E. Hermans, Ruud A. F. Krom – 1 July 1990 – Immunostaining techniques that use a monoclonal antibody against an early cytomegalovirus antigen or a polyclonal antibody, in situ DNA hybridization and inoculation of cell cultures for the detection of cytomegalovirus from liver biopsy specimens were studied in 20 liver transplant patients with cytomegalovirus hepatitis, as defined by histological criteria.

Uptake of thymidine labeled on carbon 2: A potential index of liver regeneration by positron emission tomography

Thierry M. Vander Borght, Luc E. Lambotte, Stanislas A. Pauwels, Charles C. Dive – 1 July 1990 – Noninvasive measurement of liver regeneration with positron emission tomography has been attempted with 11C‐thymidine; however, results were unsatisfactory using thymidine labeled on its methyl group.

Basal energy production rate and substrate use in stable cirrhotic patients

Manuela Merli, Oliviero Riggio, Adriana Romiti, Franco Ariosto, Lucio Mango, Giorgio Pinto, Massimiliano Savioli, Livio Capocaccia – 1 July 1990 – The basal energy production rate was measured using indirect calorimetry in 25 stable cirrhotic patients and 10 controls of comparable age. The endogenous substrate oxidation was also calculated by measuring urinary nitrogen excretion. The energy production rate was similar in cirrhotic patients and controls. The origins of liver disease and the degree of liver damage did not seem to influence the energy production rate.

Histopathology of α1‐antitrypsin liver disease in a transgenic mouse model

Stephen A. Geller, W. Stephen Nichols, Mark J. Dycaico, Katherine A. Felts, Joseph A. Sorge – 1 July 1990 – Transgenic mice were constructed using human α1‐antitrypsin M and Z genomic clones. Livers of the M lineage mice showed slight cellular pleomorphism and immunohistochemically demonstrable finely granular α1‐antitrypsin material in hepatocytes. Z lineage mice with five gene copies per haploid mouse genome (Z # 1) demonstrated fine granular α1‐antitrypsin material and a few large globules.

Computerized measurement of iron in liver biopsies: A comparison with biochemical iron measurement

John Olynyk, Pauline Hall, Richard Sallie, William Reed, Keith Shilkin, Malcolm Mackinnon – 1 July 1990 – The measurement of stainable hepatic iron using a microcomputer image analysis system was compared with standard biochemical measurements of liver iron content in 103 liver biopsy specimens–29 of idiopathic hemochromatosis, 51 of alcoholic liver disease and 23 of various nonalcoholic liver diseases. Sections were stained using Perls' method for iron; the mean area staining positively for iron was measured and expressed as a percentage of the area of biopsy measured.

Subscribe to